US Broker Ratings

argenx SE (ARGX) Stock Analysis: A Biotech Leader with a 4.62% Upside

Investors looking into the biotechnology sector may find argenx SE (ARGX) a compelling opportunity. With a market capitalization of $55.9 billion, this Netherlands-based company has gained..

Insulet Corporation (PODD) Stock Analysis: Target Price Suggests 12% Upside Potential

As the healthcare sector continues to evolve with rapid technological advancements, Insulet Corporation (NASDAQ: PODD) stands out as a key player in the medical devices industry...

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring a 4.14% Potential Upside in Biotechnology’s Rising Star

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a promising player in the biotechnology sector, is gaining traction among investors for its innovative approach to tackling metabolic dysfunction-associated steatohepatitis..

BridgeBio Pharma (BBIO) Investor Outlook: Riding a Wave of 4,318% Revenue Growth and Intriguing Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has captured investor attention within the biotechnology space, primarily due to its remarkable revenue growth and compelling potential for upside. The..

Gilead Sciences, Inc. (GILD) Rating Update: Strong Buy Ratings with a 4.47% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a heavyweight in the healthcare sector, continues to capture investor interest with its formidable presence in the biopharmaceutical landscape. With a..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Strong Buy Ratings Highlight a Promising 14.70% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) has captured the attention of investors and analysts alike, operating at the cutting edge of the biotechnology sector. With its roots..

Cardinal Health, Inc. (CAH) Stock Analysis: Navigating Growth with a 3.44% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a stalwart in the healthcare sector, presents a compelling opportunity for investors as it continues to demonstrate robust growth and strategic..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 79% Upside in the Biotech Sector

For investors seeking opportunities within the biotechnology sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents a compelling case. With a market capitalization of $7.97 billion, this Redwood..

The Ensign Group, Inc. (ENSG) Stock Analysis: Unlocking a 13% Upside in the Healthcare Sector

Investors seeking a robust opportunity in the healthcare sector might find The Ensign Group, Inc. (NASDAQ: ENSG) an enticing prospect. With a market capitalization of $10.3..

Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Sector with a 19.88% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, is capturing investor attention with its substantial potential upside of 19.88%. As a company dedicated..

Repligen Corporation (RGEN) Investor Outlook: A Healthcare Pioneer with 22.73% Upside Potential

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector with its innovative approach to bioprocessing technologies, catering to life sciences and biopharmaceutical giants globally. With..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Strong Buy with 33.89% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is capturing the attention of investors with its robust portfolio of innovative treatments and promising growth prospects. Headquartered in Dublin, Ireland,..

Hologic, Inc. (HOLX) Stock Analysis: Navigating the Healthcare Sector with a 2.72% Potential Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, is steadily making its mark in the medical instruments and supplies industry. With a market..

AstraZeneca PLC (AZN): Investor Outlook on a $276 Billion Healthcare Giant with Promising 4.55% Upside

AstraZeneca PLC (NYSE: AZN) stands as a towering presence in the healthcare sector, boasting a robust market capitalization of $276.26 billion. Specializing in the development and..

STERIS plc (STE) Stock Analysis: Investor Outlook with an 8.98% Upside Potential

In the ever-evolving healthcare sector, STERIS plc (NYSE: STE) stands out as a robust player in the medical devices industry. Headquartered in Mentor, Ohio, and with..

Charles River Laboratories (CRL) Stock Analysis: Exploring the 12.59% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, particularly within the diagnostics and research industry. With a market..

Abbott Laboratories (ABT) Stock Analysis: Exploring a 10.63% Upside Potential for Healthcare Investors

Abbott Laboratories (ABT), a prominent player in the healthcare sector, stands out as a giant in the medical devices industry with a market capitalization of $227.08..

Globus Medical, Inc. (GMED) Stock Analysis: A Strong Healthcare Contender with a 6.57% Potential Upside

Globus Medical, Inc. (NASDAQ: GMED), a prominent player in the healthcare sector, particularly in medical devices, is capturing the attention of investors with its robust growth..

Chemed Corp (CHE) Investor Outlook: Exploring a 31.84% Potential Upside

Chemed Corp (NYSE: CHE) operates at the intersection of healthcare and essential services, with its diverse portfolio encompassing hospice and palliative care through its VITAS segment,..

Exact Sciences Corporation (EXAS) Stock Analysis: Potential 22.48% Upside Ignites Investor Interest

Exact Sciences Corporation (EXAS), a prominent player in the healthcare sector, has captured investor attention with its impressive potential upside and robust product pipeline. Specializing in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds